University and Inselspital
Bern, Canton of Bern, 3010, Switzerland
NCT Number: NCT00813553
Carnosine is a natural acid buffering substance of muscle. The primary objective of this study is to test whether a nutritional supplement of beta-alanine enhances carnosine content in muscle.
Looking for future studies?
Notify Me18 year–40 year
Male
Interventional
Not applicable
Bern, Canton of Bern, 3010, Switzerland
Volunteers will be randomized to receiving 3 nutritional supplements. Two supplements contain beta-alanine at different doses, the third supplement is a placebo.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
daily
daily
Time frame: 0 to 8 weeks
Société des Produits Nestlé (SPN)
Industry
Effect of Two 8-week β-alanine Supplementation Protocols on Muscle Carnosine
Acronym: LitmusMagnet
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06967714
Behavior, Healthy
Brussels, Belgium
View Trial DetailsNCT07276464
Behavior, Colitis
Bruz, Britanny, France
View Trial DetailsNCT03886558
Aging, Behavior
Pontevedra, Spain
View Trial DetailsNCT03876314
Alzheimer Disease, Behavior
Greensboro, North Carolina, United States
View Trial Details